ENTITY
Lepu Biopharma

Lepu Biopharma (2157 HK)

70
Analysis
Health Care • China
Lepu Biopharma Co. Ltd. is an innovation-driven biopharmaceutical company focused on discovering, developing, and commercializing drug candidates in anti-tumor targeted therapy and oncology immunotherapy. The company's pipeline includes ADCs, immunotherapies, and oncolytic virus drugs, with commercial products like Puyouheng and Meiyouheng. It was founded in 2018 and is headquartered in Shanghai, China.
more
•27 Feb 2022 07:47

ECM Weekly (27th Feb 2022) - LIC, SBI Sumishin, Farm Fresh, Yunkang, Shanghai Pulse, Jinmao, IDP Edu

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
493 Views
Share
•25 Feb 2022 10:16

Jinmao Property Services IPO - Premium Asking Valuation and Cornerstones Took up 80% of Deal

Jinmao Property Services (JM HK) is looking to raise around US$105m in its Hong Kong IPO. In this note, we will look at deal dynamics, assumptions,...

Logo
545 Views
Share
bearish•Yunkang Group
•24 Feb 2022 14:14

Yunkang Group Pre-IPO - Would Need to Prove Itself Post-COVID

Yunkang Group (YK HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. While it has managed to grow its on-site centers, it has to...

Logo
416 Views
Share
•22 Feb 2022 11:37

Lepu Biopharma (乐普生物科技) IPO Trading: High Share Concentration

We provide an update on latest information on Lepu Biopharma prior to debut tomorrow. Subscription is poor and the shares are highly concentrated.

Logo
259 Views
Share
•20 Feb 2022 08:55

ECM Weekly (20th Feb 2022) - LIC, SBI Sumishin, Huitongda, Delhivery, Vedant, Persol, Emcure, Linom

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
493 Views
Share
x